International Journal of Rheumatology is a peer-reviewed, open access journal that publishes…
www.hindawi.com|By Hindawi Publishing Corporation
Scleroderma is possibly the most challenging autoimmune disease to treat, mainly because we still lack effective treatment tools for its fibrosing complications: especially in the skin and the lungs. Targeting IL6 looks promising.
